Joint (NASDAQ:JYNT – Get Free Report) is projected to release its Q1 2025 earnings data after the market closes on Thursday, May 8th. Analysts expect Joint to post earnings of ($0.02) per share and revenue of $13.02 million for the quarter.
Joint Trading Down 5.6 %
Joint stock opened at $9.90 on Tuesday. The firm has a market capitalization of $151.70 million, a P/E ratio of -8.68 and a beta of 1.54. Joint has a twelve month low of $9.58 and a twelve month high of $17.82. The stock’s fifty day simple moving average is $10.98 and its 200-day simple moving average is $11.09.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded Joint from a “buy” rating to a “hold” rating in a report on Monday, March 17th.
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
See Also
- Five stocks we like better than Joint
- Top Stocks Investing in 5G Technology
- Monster Beverage Stock: Short Report Risks vs Upside Potential
- High Flyers: 3 Natural Gas Stocks for March 2022
- Onsemi Stock Confirms Bottom, But What’s the Upside?
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Tech Leaders Announce Buybacks Totaling $85 Billion
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.
